Biohaven Pharma (BHVN) Tops Q1 EPS by 41c
Biohaven Pharma (NYSE: BHVN) reported Q1 EPS of ($0.98), $0.41 better than the analyst estimate of ($1.39).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Biohaven Pharma (NYSE: BHVN) reported Q1 EPS of ($0.98), $0.41 better than the analyst estimate of ($1.39).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.